Selected article for: "cerebrovascular disease and respiratory disease"
Author: Alhashim, Ali; Alqarni, Mustafa; Alabdali, Majed; Alshurem, Mohammed; Albakr, Aishah; Hadhiah, Kawther; Aljaafari, Danah; Alyami, Rawan
Title: Large Vessel Occlusion Causing Cerebral Ischemic Stroke in Previously Healthy Middle-Aged Recently Recovered from Severe COVID-19 Infection
  • Cord-id: f7ipzxcm
  • Document date: 2021_8_29
    • ID: f7ipzxcm
    Snippet: BACKGROUND: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has led to an unprecedented worldwide pandemic with diverse respiratory symptoms as well as systemic manifestations and complications. The neurological manifestations of COVID-19 include, but are not limited to, headache, cerebrovascular disease, and skeletal muscle injury. CASE REPORT: Herein, we present a case of stroke with large vessel occlusion in a middle-aged man, who re
    Document: BACKGROUND: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has led to an unprecedented worldwide pandemic with diverse respiratory symptoms as well as systemic manifestations and complications. The neurological manifestations of COVID-19 include, but are not limited to, headache, cerebrovascular disease, and skeletal muscle injury. CASE REPORT: Herein, we present a case of stroke with large vessel occlusion in a middle-aged man, who recently recovered from severe SARS-CoV-2 infection. This patient is not known to have any medical illness or surgical history and has no cerebrovascular risk factors. Moreover, the patient underwent extensive investigations, including neuroimaging, cardiac and laboratory work-up with no evidence of stroke etiology. CONCLUSION: The mechanism of cerebrovascular events in the setting of COVID-19 is still uncertain and probably multi-factorial. The prevailing hypothesis is a strong thrombotic tendency, which may even be prolonged after complete recovery. In our patient’s case, hypercoagulability in the context of viral infection is the most likely mechanism for the stroke. Further studies are needed to find out the exact pathogenesis of thromboembolic events in the setting of COVID-19 infection as well as the efficacy, safety, dosage, and duration of anticoagulants in such conditions.

    Search related documents:
    Co phrase search for related documents
    • active sars infection and acute respiratory distress syndrome: 1, 2, 3
    • active sars infection and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active sars infection patient and acute respiratory syndrome coronavirus: 1
    • acute ards respiratory distress syndrome and low density: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and low density lipoprotein: 1
    • acute ischemic stroke and low density: 1, 2, 3, 4, 5
    • acute ischemic stroke and low density lipoprotein: 1, 2, 3, 4
    • acute ischemic stroke and low density lipoprotein ldl: 1, 2
    • acute management and low density: 1
    • acute onset and low density: 1
    • acute onset and low density lipoprotein: 1
    • acute onset and low density lipoprotein ldl: 1
    • acute respiratory distress syndrome and low density: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and low density lipoprotein: 1, 2
    • acute respiratory distress syndrome ards and low density: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome ards and low density lipoprotein: 1
    • acute respiratory syndrome coronavirus and low density: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute respiratory syndrome coronavirus and low density lipoprotein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory syndrome coronavirus and low density lipoprotein ldl: 1, 2, 3, 4, 5